Literature DB >> 17609342

Detection of botulinum type E toxin in channel catfish with visceral toxicosis syndrome using catfish bioassay and endopep mass spectrometry.

Patricia S Gaunt1, Suzanne R Kalb, John R Barr.   

Abstract

Visceral toxicosis of catfish (VTC) is a syndrome characterized by sudden mortality in apparently healthy market- and brooder-sized catfish (Ictalurus punctatus). This paper reports the design of a catfish neutralization assay to detect botulinum in catfish with VTC and verification by Endopep mass spectrometry (Endopep-MS). Sera from 6 affected catfish were incubated with botulinum antitoxin serotypes A, B, C, D, E, or F. For each serum sample, 3 experimental fingerlings were injected intracoelomically with each serotype-serum mixture and placed separately in an aquarium. Three fish were injected with VTC-affected serum only, and 3 fish were injected with unaffected serum only and also placed in separate aquaria. Signs of morbidity and mortality were seen in fish injected with sera combined with serotype A, B, C, or D, as well as in positive controls. No morbidity or mortality was seen in fish injected with sera combined with antitoxin serotypes E or F or negative control serum. Sera from affected and unaffected catfish were sent to Centers for Disease Control and Prevention for detection and differentiation of botulinum neurotoxin. Aliquots of 0.5 ml of sera were incubated with magnetic beads coated with antibodies to botulinum, and the beads were subjected to the Endopep-MS reaction. Sera from affected catfish tested positive for botulinum E. Sera from 34 unaffected catfish tested negative for botulinum. Although there was not enough botulinum present in affected samples to obtain exact quantification, the estimated quantity of botulinum E in these sera samples was between 0.01 and 0.5 mouse LD50/ml.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609342     DOI: 10.1177/104063870701900402

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  8 in total

1.  A fluorescence detection platform using spatial electroluminescent excitation for measuring botulinum neurotoxin A activity.

Authors:  Kim E Sapsford; Steven Sun; Jesse Francis; Shashi Sharma; Yordan Kostov; Avraham Rasooly
Journal:  Biosens Bioelectron       Date:  2008-06-18       Impact factor: 10.618

2.  In vitro detection and quantification of botulinum neurotoxin type e activity in avian blood.

Authors:  Timothy M Piazza; David S Blehert; F Mark Dunning; Brenda M Berlowski-Zier; Füsûn N Zeytin; Michael D Samuel; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2011-09-09       Impact factor: 4.792

3.  Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.

Authors:  Dongxia Wang; Joan Krilich; Jakub Baudys; John R Barr; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2014-09-16       Impact factor: 3.365

4.  Lab-on-a-chip for botulinum neurotoxin a (BoNT-A) activity analysis.

Authors:  Steven Sun; Miguel Ossandon; Yordan Kostov; Avraham Rasooly
Journal:  Lab Chip       Date:  2009-09-17       Impact factor: 6.799

5.  Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.

Authors:  Suzanne R Kalb; Consuelo Garcia-Rodriguez; Jianlong Lou; Jakub Baudys; Theresa J Smith; James D Marks; Leonard A Smith; James L Pirkle; John R Barr
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

6.  Sensing the deadliest toxin: technologies for botulinum neurotoxin detection.

Authors:  Petr Capek; Tobin J Dickerson
Journal:  Toxins (Basel)       Date:  2010-01-07       Impact factor: 4.546

7.  Zebrafish Sensitivity to Botulinum Neurotoxins.

Authors:  Kamalakar Chatla; Patricia S Gaunt; Lora Petrie-Hanson; Lorelei Ford; Larry A Hanson
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

8.  Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.

Authors:  Suzanne R Kalb; Jianlong Lou; Consuelo Garcia-Rodriguez; Isin N Geren; Theresa J Smith; Hercules Moura; James D Marks; Leonard A Smith; James L Pirkle; John R Barr
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.